New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
12:26 EDTZMHZimmer down slightly after FDA recalls PEEK Ardis Inserter
The FDA announced that it was issuing a Class I recall for Zimmer Spine's (ZMH) PEEK Ardis Inserter. A Class I recall is issued when the FDA believes that there is a reasonable probability that the use of a product could cause serious health problems. The device is used to insert Zimmer's PEEK Ardis Interbody Spacer during spinal surgery. Zimmer was told that the spacer has broken into fragments when too much lateral force is applied to the inserter in some cases, the FDA reported. As a result, patients may experience various adverse effects, including a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, according to the agency. Long-term health risks may include disability, dysfunction, or death, it added. The FDA's recall was initiated on December 21. Zimmer, on December 20, had initiated a voluntary recall of all 315 of its PEEK inserter units. Zimmer said at that time that it had received reports of the spacer implant breaking, but did not list adverse health effects that could occur if the implant breaks. In early afternoon trading, Zimmer fell 38c, or 0.57%, to $66.35.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
10:33 EDTZMHHigh option volume stocks
High option volume stocks: KBR LM PRGO CHRW DG ZMH LGF ZTS OSIR REGI
November 19, 2014
09:11 EDTZMHZimmer reports Synovasure PJI test earns certification
Subscribe for More Information
November 18, 2014
07:30 EDTZMHZimmer agrees with EC to extend deal review deadline by 'limited number of days'
Zimmer Holdings announced that it has agreed with the European Commission to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a "limited number of days" in order to provide the EC with certain additional information. Under the previous timeline, the EC had until March 11, 2015 to make a final decision on the proposed transaction. As a result of this extension, the deadline for the EC's final decision will be extended by the limited amount of additional time that Zimmer has agreed to provide to the EC. "Deadline extensions are not uncommon in such in-depth investigations. Zimmer has been working closely with the regulatory authorities to facilitate their review of the pending transaction and is encouraged by the substantial progress that has been made to date in connection with the overall regulatory process. Zimmer continues to expect to close the transaction in the first quarter of 2015," the company said.
November 10, 2014
09:01 EDTZMHZimmer announces FDA clearance of Optio-C anterior cervical system
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use